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Abstract 
A less frequent complications of shunt 
systems ventriculoperitoneal used for the 
management of hydrocephalus is the allergy 
materials which usually are built, silicone 
and latex. Patients undergoing multiple 
changes device may be at risk of developing 
high rejection to materials. Differential 
diagnosis should be done with infections 
and obstructions, usual causes of 
dysfunction. We present a review updated 
literature focused neurosurgeon. 
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Introduction 
The biomaterials used in the central 
nervous system include silicone, lipids, 
natural polymers and synthetic polymers in 
various forms based on their applications 
(1). 
Biocompatibility of implants in humans 
has been classified as “inert”, “tolerated”, 
and “bioactive” (2). Today is well known 
that silicone and latex are not inert 
materials, so the body can react in different 
ways respect to them. 
The cerebrospinal fluid (CSF) shunts 
typically consist of a proximal catheter, 
which runs from the cerebral ventricles’ 
subarachnoid spaces to a valve that connects 
to a distal catheter and regulates the 
drainage of CSF (1). The distal catheter is a 
long thin silicone tube that is placed 
subcutaneously and terminates in a distal 
body cavity where the CSF can be 
reabsorbed into the body (3-5). In shunt-
treated patients, catheter-induced 
complications account for up to 70% of all 
hardware failures (2), the remainder are due 
to conditions like allergy or hypersensitivity 
to latex, and more rarely to silicone, this has 
now become a worrying health concern, 
that not only affects patients with multiple 
surgical interventions, but health care 
workers too (6).The aim of this review is to 
remember the clinical relevance of CSF 
shunt related hypersensitivity and allergy, 
and management repercussions in these 
circumstances. 
Epidemiology 
Silicon:  
The incidence of silicone ventricular 
shunt allergies is rare. Evidence of silicone 
allergy may have been origin for certain 
complications in breast and joint implants is 
present since 1984, when Gower et al. (7) 
using electron microscopy, postulated that a 
small subset of shunt malfunctions could be 
attributed to silicone allergy. In 1989, Snow 
and Kossovsky (8), studied the clinical and 
pathological findings in 29 patients who 
underwent surgical procedures to revise 
malfunctioning ventriculoperitoneal 
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shunts. A pathologist independently 
examined the shunt hardware removed, and 
was observed that three patients had 
evidence of some hypersensitivity reaction 
due to the shunt hardware (multiple 
eosinophils and giant cells in tissue 
enveloping shunt hardware). In 1992, 
Goldblum, et al. (9) reported two patients 
who showed severe reactions to 
ventriculoperitoneal (VP) shunts, using 
ELISA they demonstrated that patients had 
increased quantities of serum IgG, 
indicating an immunemediated reaction. In 
1994, Jimenez et al. (10) reported three 
hydrocephalic patients who developed a 
clinically heterogeneous entity with an 
allergic rejection of their silicone 
ventriculoperitoneal shunts. Clinically, the 
presentation was indicative of shunt 
infection, but in all three patients there was 
a sterile CSF. Patients had recurrent skin 
breakdowns over the shunt tract, 
subsequent infections and development of 
fungating granulomas. The treatment 
included the replacement in one patient the 
silicone shunt material to polyurethane plus 
inmunossupression and in the other 
patients, the original shunt system was 
removed without a replacement. In 1999 a 
single case of bowel perforation caused by 
silicone shunt allergy was reported (11). 
Latex:  
When allergies to medical biomaterial do 
occur, the causative agent is often latex (12, 
13). Case reports of allergic reactions to 
latex proteins have been described with 
various products from 1927 (14, 15), but 
since 1979 (16), IgE-mediated allergy to 
latex has drawn much attention.  
Latex sensitization remains the second 
most common cause of anaphylaxis 
(16.9%), during anesthesia in the general 
population (17, 18). Children with 
myelomeningocele or spina bifida (SB) and 
urogenital abnormalities have high 
incidence of IgE-mediated allergic 
reactions, probably due to a high degree of 
exposure to latex products through repeated 
surgical procedures, catheterization, and 
implant of latex-containing material (19, 
20). Particularly, patients with SB have 
more severe and unexpected allergic 
reactions, linked with surgical procedures 
(21, 22). Patients with sensitization have a 
500 times greater risk of serious reactions 
related to latex intraoperatively than that of 
the general population (23). 
Nieto et al (24), in their 100 patient 
series with spina bifida, found a 29% 
prevalence of sensitization to latex; among 
patients with a V-P shunt, sensitization to 
latex was present in 36%, but there was not 
a single case of sensitization among those 
patients without it. They tried to identify 
those factors that may have a causal or 
predisposing role in the process of 
sensitization, the analysis disclosed many 
significant variables, but closely linked. As 
age increases, so does the rate of 
sensitization, but also an increase in the 
number of surgical procedures and, in the 
number of all diagnostic and therapeutic 
procedures, as well as in the absolute levels 
of serum total IgE. Logistic regression 
analysis selected the variable “number of 
operations” as the one that most 
contributed to the process of sensitization. 
Three other variables (serum total IgE 
levels, presence of a V-P shunt, and 
personal antecedents of atopic disease in 
this order) were synergistic and included to 
build the most parsimonious model. V-P 
shunt devices are made of silicone and do 
not contain latex, but has been suggested its 
co-adjuvant role as a foreign body in the 
process of sensitization.  
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Kattan et al. (25) reported the results of 
fifty-nine patients, aged 1-20 years, with SB 
that were evaluated by a questionnaire on 
type of latex reactions; family and personal 
history of other allergic disorders, such as 
asthma, rhinitis, and urticaria; type and 
number of surgical procedures; and 
frequency of bladder catheterization and 
manipulation with latex materials. 
Confirmation of latex sensitivity was 
measured by skin prick test (SPT), CAP 
test, and latex skin challenge. They found 
allergy to latex in 25% of the study group. 
There was a significant variation in allergic 
reaction by sex (males 42%, females 12%) 
(P<0.01), use of catheters (yes 38%, no 
13%) (P<0.05), and urologic surgery (yes 
60%, no 18%) (P<0.01). The number of 
surgical procedures, age of patient, and V-P 
shunt were not significantly related to 
allergic reactions, they have no explanation 
for the difference in their patients, other 
than the possibility of genetic differences 
and, perhaps, extra precautions taken by 
surgeons in minimizing the use of latex 
articles in such patients. Tangsinmankong 
et al. (26) reported a case of a patient with 
congenital hydrocephalus and a V-P shunt, 
who developed CSF eosinophilia associated 
with latex allergy and shunt malfunction. 
Latex allergy 
Latex is an emulsion product from 
Hevea brasiliensis trees (27). Today nearly 
all commercial natural rubber comes from 
latex of those trees, commercially grown in 
a number of tropical countries. Another 
source of latex is the guayule bush 
(Parthenium argentatum) (28). 
Interestingly the latex from the guayule 
bush does not appear to contain proteins 
cross-reactive with the allergens of Hevea 
latex (29). Other closely related materials 
that have been reported to be potentially 
cross-reactive with Hevea latex are gutta-
percha and gutta-balata from Sapotaceae 
trees (30). Natural latex is widely used in 
the medical field (e.g., gloves, catheters, 
tubing, syringes, tourniquets), but also in 
everyday life (pacifiers, balloons, children's 
toys, hats and slippers pools, mattresses, 
shoes, clothes, condoms). Latex allergy is a 
type I allergy, i.e., IgE mediated. Patients 
are often associated with food allergy 
focusing on the fruit (31), especially banana 
(15). Crossed latex and food allergy 
constitutes a phenomenon of particular 
concern because the list of food allergens 
probably involved is steadily increasing. 
The prevalence of latex allergy is well 
known in certain risk groups such as those 
patients with multiple surgical 
interventions and among health care 
professionals (31, 32). 
Latex proteins are numerous, and allergy 
to latex is related to a complex mixture of 
proteins (33-35).The risk of anaphylaxis is 
suggested by history of atopic diseases, such 
as asthma, allergic rhinitis, food allergy, and 
urticaria, or previous allergic symptoms on 
exposure to latex-containing materials (25). 
A series of distinct proteins occurring at 
either high (Heb b 6) or very low 
concentration (Hev b 1–5, Hev b 7–13) in 
the Hevea brasiliensis latex, have been 
identified as the IgE-binding allergens 
responsible for sensitization (36, 37). 
Children at risk for developing latex allergy, 
are those with allergy to bananas, kiwifruits, 
avocado, stone fruits, papaya, carrot, raw 
potato, tomato, chestnuts or peanuts, and 
those with history of a latex glove-
associated contact dermatitis (38).  
Silicon allergy 
Silicone rubber is a polymer biomaterial 
of the first generation (39), silicone is a 
group of synthetic polymers called 
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organopolysiloxanes, with a molecular 
structure consisting of alternating silicon 
and oxygen atoms (40). Silicones can be 
fluids, gels, or solids (elastomers), 
depending on the length of the polymeric 
chain and the degree of crosslinking (10). 
CSF shunt devices are manufactured almost 
solely from medical grade silicone, owing to 
its chemical stability, minimal biological 
reactivity, low toxicity and 
noncarcinogenicity (41-43). Currently, 
silicone is used to make the following shunt 
components: catheters, access chambers, 
valve mechanisms, suture clamps and 
external valve housings (1). Silicones are 
used as encapsulants, adhesives, or coatings 
in medical devices. They are commonly 
used in cerebrospinal fluid shunts, 
intravenous tubing, drug delivery systems, 
cardiac valves, arthroplasty prostheses, and 
intraocular lens implants (10).  
Allergy to shunting tube is rare (44), 
probably because of its high 
biocompatibility and low biological 
reactivity (45). Silicone has been considered 
safe and chemically inert, but immune 
mechanisms related to silicone materials 
have been proposed for some cases of 
obstruction of V-P shunts, because of 
inflammatory cells detected in the tubing 
lumen (46, 47), and for the evidence 
derived from patients and from animal 
experimental data to suggest that silicone 
can act as an antigen of a hapten complexed 
to self-proteins (7-9, 48-53) and could elicit 
inflammatory reactions, confirming that 
silicone is not inert biologically. 
Furthermore, has been demonstrated that 
silicone gel is a potent humoral or antibody 
adjuvant (54), and solid silicone implant 
can produce a similar type of 
hypersensitivity (55). 
Implanted silicone prostheses and 
medical devices are associated with various 
local (mild fibrosis (56)) and systemic host 
inflammatory reactions, they have been 
associated with a form of autoimmune 
disease (51, 57). Heggers et al. (53) 
investigated the possibility of a cellular 
immune response to implanted silicone in 
an animal model. They observed 
histologically that the cellular response to 
polydimethylsiloxane in sensitized guinea 
pigs is consistent with a cellular immune 
reaction. Electron Microscopy and X-ray 
energy spectroscopy have demonstrated 
intracellular silicon in the intracellular 
machinery (Golgi apparatus, rough 
endoplasmic reticulum, and at both ends of 
cytoplasmic bridges) in macrophages and 
lymphocytes. Suggesting that those cells are 
processing a silicon-containing complex as 
an antigen (53). According to this theory, 
macrophages recruited to a foreign body 
reaction could release oxidizing free radicals 
capable of attacking the silicone present to 
liberate the irritating silica, but, this cannot 
be the sole mechanism responsible since 
fluid or gel silicone do not contain silica 
fillings and have also been shown to be 
irritants (53). Kossovsky et al. (48), also 
tested the hypothesis that silicones may 
evoke an immunologically mediated 
inflammatory reaction in a guinea pigs 
model, they found that animals stimulated 
with silicone-serum and those passively 
sensitized had four times greater palpable 
lesions at approximately 24 h compared to 
controls (saline solution)when challenged 
to different intradermal antigens (silicone-
homologous serum, pure silicone, saline-
homologous serum, and purified protein 
derivative), biopsies revealed a moderate to 
marked lymphocytic infiltrate. Control sites 
and naive animals showed only edema at 
the challenge sites, also suggesting that 
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silicone-protein complexes are potentially 
immunogenic.  
First cases of silicone allergy were 
encountered with the use of silicon stents 
(58, 59), the histological examination of the 
material embracing and occluding the tube, 
was founded abundance of eosinophils and 
giant cells, meaning an allergic reaction to 
the silicone material (44). 
Unfortunately, the nature of the silicone 
antigen that elicits the immune response is 
not well known (9), another hypothesis to 
explain or justify the inflammatory 
reactions associated with silicone shunts is 
the electrostatic active internal surface of 
the silicone hardware, that gives the 
potential to increase the adherence of 
airborne particles to the shunt and facilitate 
a foreign tissue reaction by the body leading 
to a hypersensitivity condition (7, 60, 61). 
Apparently, the most frequent silicone 
allergy seems to be a type IV or delayed-
type hypersensitivity reaction (9). This 
reaction is mediated by T cells and starts 2 
to 7 days after the exposure. Interestingly, 
Hashimoto et al. (62) reported the case of a 
patient with an abdominal CSF pseudocyst 
that resulted from an allergic reaction to 
silicone. The patient underwent repair 
surgery of the meningomyelocele associated 
with the Chiari II malformation, and the V-
P shunt was instituted at 6 months of age. A 
formation of the abdominal CSF 
pseudocyst and the consequent shunt 
malfunction were observed 40 days after the 
V-P shunt. An increase in the number of 
the peripheral eosinophils and serum 
immunoglobulin E (IgE), and an 
infiltration of eosinophils in the specimen 
harvested from the pseudocyst wall 
suggested an allergic reaction as the cause of 
the pseudocyst. A sixth operation to revise 
the V-P shunt was performed using the 
shunt system made of “extracted silicone”, 
which was produced extracting the allergic 
substances. The serum IgE was normalized 
after surgery and the abdominal CSF 
pseudocyst has not recurred for 22 months. 
Clinical presentation 
In the case of silicon shunt allergy:  
The allergic reactions typically occur 
through local reaction, silicone migration, 
or human autoimmune disease. The patient 
may present to the emergency room with 
symptoms of either indolent shunt 
infection due to irritability and low grade 
fever or shunt obstruction due to 
aggregation of the fenestrated catheter tip 
with eosinophils and giant cells (44). Can 
be present CSF eosinophilia (44, 63). 
In the case of latex shunt allergy:  
Overall, children at high risk for serious 
reactions, are those with history of 
anaphylaxis to latex, history of allergy to 
latex or rubber (urticaria, dermatitis, eye 
swelling, bronchospasm), history of atopy, 
history of multiple (>5) surgical 
procedures: spina bifida, genitourinary 
anomalies (38). 
Symptoms of latex allergy can range 
from mild urticarial to life-threatening 
events and death.  
Exposure to latex can cause type I 
immunoglobulin (Ig) E mediated 
hypersensitivity reactions or more 
commonly an allergic contact dermatitis 
(type IV) (38). Clinical allergy to latex is 
indicated by repeated immediate reaction 
on latex exposure, including itching, hives, 
rhinoconjunctivitis, bronchospasm, 
angioedema, hypotension, and contact 
urticaria (64, 65). Also can be present CSF 
eosinophilia (66). 
Diagnosis and management 
Silicone:  
In cases of recurrent malfunctions in 
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which the origin remains unclear despite 
extensive routine investigations, it would be 
appropriate to consider diagnosis of silicone 
shunt allergy (44). Diagnosis of silicone 
allergy requires first ruling out other forms 
of shunt complications, such as infection 
and obstruction (44). Potential triggers 
other than silicone, such as intravenous or 
topical antibiotics like bacitracin, must also 
be examined (44). SPT and Immuno-CAP 
are sensitive and reliable diagnostic tools in 
detection of SB patients who are at high 
risk of developing allergic reactions to latex 
and should be used routinely to exclude the 
use of latex products in sensitized patients 
(25). 
Jimenez et al. (10) recommended a 
battery of resources for evaluating silicone 
allergy such as assays for erythrocyte 
sedimentations rate, complement and 
immunoglobulin levels, fluorescent nuclear 
antibodies, ribonucleic proteins, extractable 
nuclear antibodies, and rheumatoid factor, 
tissues biopsy and human leukocyte antigen 
typing. They also recommended 
performing ELISAs for antisilicone IgG 
antibodies when available. Furthermore is 
recommended the pathological examination 
of the failed hardware. 
The ELISA for antisilicone IgG 
antibodies was first described by Goldblum, 
et al (9). They demonstrated that ELISA is 
specific to symptomatically allergic patients 
and not just individuals exposed to silicone 
(44). Because of the multifaceted nature of 
the reaction to silicone in the rare instance 
that it does occur, treatment must involve 
complete removal of the silicone hardware:  
- Shunt system can be removed without 
replacement if the patient can 
tolerate it (10). 
- Shunt removal can be accompanied by 
a third ventriculostomy (this could 
be difficult in patients with 
complicated anatomy due to 
multiple surgeries) (44) 
- Shunt-dependent patients can have the 
silicone-based hardware removed 
and replaced with non-silicone based 
hardware (e.g., polyurethane VP 
system, if this is selected, is 
recommended to consider long-term 
immunosuppression (10)). 
In the case reported by Tangsinmankong 
et al. (26), they used a daily treatment with 
2 mg/kg of methylprednisolone, and 
observed a reduction of the peripheral 
eosinophilia and slightly reduced CSF 
eosinophil counts. Pulse 
methylprednisolone, 15 mg/kg, was 
associated with complete reduction of CSF 
eosinophils and prolonged VP shunt 
survival. 
Latex:  
A sensitive, specific, and safe skin test for 
latex sensitivity appears superior to in vitro 
testing for latex allergy. Age, number of 
surgical procedures, and the presence of 
positive allergen skin test responses are 
significantly correlated with latex 
sensitization. Age alone is significantly 
correlated with clinical allergy to latex (65). 
Testing for type I natural rubber latex 
allergy is through serum testing, such as 
RAST (radioallergosorbent test), which 
identifies what types of IgE proteins trigger 
allergic reactions.  
Currently the only effective preventative 
strategy is latex avoidance (38). Some 
recommendations in the operating room 
are: Patient should be first on the list, latex-
free theatre for at least 2 hours (ideally 
overnight) prior to case; all staff involved in 
patient care must be made aware of latex 
allergy status and warning signs should be 
posted outside the operating theatre; a 
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latex-free trolley/box should be present 
with every case, which follows the patient 
from pre-assessment to postoperative care, 
and develop completely latex-free surgical 
areas (38). 
Conclusions 
Hydrocephalus shunt catheters cannot 
be termed “inert” or “biotolerated”. Rather, 
they must be regarded as “bio-active” 
implants. The extensive reaction on 
silicated catheters can act as reference to 
estimate the biocompatibility of surface 
modifications (2). 
SB patients with a history of repeated 
urologic procedures and a history of 
urticaria, especially male patients with such 
history, are most likely to develop allergy to 
latex products. 
We conclude that pathological 
examination of shunt hardware is helpful in 
understanding noninfectious causes of 
shunt malfunction. We have identified a 
subgroup of patients who developed a 
hypersensitivity-like reaction around the 
shunt that in certain instances lead to shunt 
malfunction. 
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